- CSR Summary Not Yet Available
- NCT01474109
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameMacitentanProduct NameOPSUMIT®Therapeutic AreaRespiratory Tract (Lung and Bronchial) DiseasesEnrollment289% Female85.8%% White88.5%
Product ClassEndothelin Receptor AntagonistSponsor Protocol NumberAC-055C301Data PartnerJohnson & JohnsonCondition StudiedScleroderma, SystemicMean/Median Age (Years)51.2
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available